#market access
5 articles with this tag
Payer Strategy Time Management for Pharma CEOs
How pharma and biotech CEOs engage in payer strategy at the right executive level without becoming enmeshed in managed care contract negotiations.
Pharma CEO Time Management: Governing Health Economics Strategy for Market Access Success
How pharma CEOs invest time in health economics and outcomes research strategy, value dossier development, and the economic evidence that drives reimbursement decisions.
Pharma CEO Time Management: Integrating Real-World Evidence Into Strategic Decision-Making
How pharma CEOs invest time in real-world evidence strategy, payer implications, and cross-functional coordination between medical affairs, market access, and commercial.
How Biosimilar Company CEOs Manage Time Across Development and Market Access
Biosimilar company CEO time management: FDA approval process, interchangeability strategy, payer formulary relationships.
Market Access Strategy Pharma CEO: Time Management Across Regions and Payer Environments
Time management strategies for pharma CEOs driving market access strategy across multiple regions, payer environments, and reimbursement systems.